Related Experiment Videos
Systemic hemodynamic effects of endothelin in rats
A J King1, J M Pfeffer, M A Pfeffer
1Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
The American Journal of Physiology
|March 1, 1990
Summary
Endothelin-1 (ET-1) causes initial vasodilation and later vasoconstriction, impacting blood pressure and cardiac output. This peptide may influence vascular tone and vasospastic disorders.
Area of Science:
- Cardiovascular Physiology
- Endocrinology
Background:
- Endothelin type 1 (ET-1) is a potent vasoconstrictor peptide derived from endothelial cells.
- Its systemic hemodynamic effects and comparison to angiotensin II (ANG II) require detailed investigation.
Purpose of the Study:
- To investigate the systemic hemodynamic effects of ET-1 in rats.
- To compare the cardiovascular responses to ET-1 and ANG II.
Main Methods:
- Anesthetized male Munich-Wistar rats received intravenous bolus injections of ET-1 or ANG II.
- Mean arterial pressure (AP), right atrial pressure (RAP), and cardiac index (CI) were measured over 60 minutes.
Main Results:
- ET-1 induced biphasic AP response: transient hypotension (vasodilation) followed by dose-dependent hypertension.
- Late-phase hypertension with ET-1 was linked to decreased CI and increased total peripheral resistance index (TPRI), suggesting plasma volume contraction.
- ANG II caused a faster, more potent, but shorter hypertensive response than ET-1 with fewer hemodynamic alterations.
Conclusions:
- ET-1 exhibits complex hemodynamic effects, including initial vasodilation and subsequent potent vasoconstriction.
- ET-1's actions suggest a potential role in regulating vascular smooth muscle tone and the pathophysiology of vasospastic conditions.